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Cryptococcus isolates from AIDS patients in southern
California were characterized by molecular analyses.
Pheromone MFα1 and MFa1 gene fragments were poly-
merase chain reaction–amplified with fluorescently labeled
primers and analyzed by capillary electrophoresis (CE) on
DNA analyzer. CE–fragment-length analyses (CE-FLAs)
and CE–single-strand conformation polymorphisms (CE-
SSCPs) were used to determine Cryptococcus gattii (Cg),
C. neoformans (Cn) varieties neoformans (CnVN) and gru-
bii (CnVG), mating types, and hybrids. Corroborative tests
carried out in parallel included growth on specialized media
and serotyping with a commercial kit. All 276 clinical strains
tested as haploid MATα by CE-FLA. CE-SSCP analyses of
MFα1 showed 219 (79.3%) CnVG, 23 (8.3%) CnVN, and
34 (12.3%) Cg isolates. CE-FLA and CE-SSCP are promis-
ing tools for high-throughput screening of Cryptococcus
isolates. The high prevalence of Cg was noteworthy, in
view of its sporadic reports from AIDS patients in North
America and its recent emergence as a primary pathogen
on Vancouver Island, Canada.
T
he encapsulated basidiomycete Cryptococcus neofor-
mans was recently divided into 2 species, C. neofor-
mans (Cn) and C. gattii (Cg) (1). Cn consists of 2 varieties,
grubii (CnVG) and neoformans (CnVN), which are oppor-
tunistic pathogens and predominantly infect immunocom-
promised persons (2,3). CnVG is the major causative agent
of cryptococcosis worldwide, except in central Europe,
where CnVN infection is most prominent. In contrast, Cg
is a primary pathogen, which predominantly infects
immunocompetent persons (4). Cg was previously thought
to be restricted to tropical and subtropical climates with a
special ecologic niche on Eucalyptus trees (5,6). However,
the recent outbreak of Cg infection in healthy humans and
animals in the temperate climate of Vancouver Island,
British Columbia, Canada, and its isolation from several
species of trees other than Eucalyptus have raised the
strong possibility that this fungus might have broader geo-
graphic distribution (7–9).
The mechanisms underlying pathogenic and environ-
mental differences between Cn and  Cg are not known.
Within Cn species, CnVN infections are more likely to dis-
play skin involvement and to afflict older patients, where-
as CnVG infections are reported to cause a higher mortality
rate (3,10). In contrast, infections caused by Cg result in a
lower mortality rate but are frequently complicated by neu-
rologic sequelae and require surgery and prolonged thera-
py (4,11). Our recent studies with the Cu,Zn SOD (SOD1)
and MnSOD (SOD2) knockout mutants of Cg indicated
that these antioxidants are crucial for Cg pathogenesis
(12,13). In contrast, the antioxidant function of SOD1 in
CnVG is less crucial for pathogenesis (14). These observa-
tions are the first molecular evidence of a likely divergence
in the pathogenic mechanisms used by Cn and Cg.
Both Cn and Cg have a single locus, 2-allele mating
system comprising MATα and MATa strains. The MATα
strains of Cn and Cg predominate in nature and in clinical
settings, and this predominance over MATa strains is
linked to high virulence and reproduction by haploid fruit-
ing (3,15). Generally, Cryptococcus strains are haploid, but
hybrid strains have also been characterized from both clin-
ical and environmental sources (16–20). Thus, characteriz-
ing clinical Cryptococcus isolates to the individual species
or varieties and according to mating and hybrid types
could be useful for managing cryptococcosis cases and for
further understanding the epidemiology of this disease.
Several laboratory typing methods have been used in
epidemiologic studies of cryptococcosis, including
serotyping, electrophoretic karyotyping, use of mitochon-
drial DNA probes, use of genomic DNA probes, determi-
nation of allelic variations at the URA5 locus, multilocus
enzyme typing, measurement of creatinine utilization,
polymerase chain reaction (PCR), fingerprinting and
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[2]). Previously, we described a PCR–restriction fragment
length polymorphism (PCR-RFLP) typing scheme for Cn
and Cg pheromone genes, which could be used for charac-
terizing mating types, hybrids, and variety (21). In the
present study, we developed a capillary
electrophoresis–fragment length analysis (CE-FLA) test,
and a CE–single stranded conformation polymorphism
(CE-SSCP) test by using the pheromone genes MFα1 and
MFa1. These tests were used in parallel with more tradi-
tional specialized culture medium and a commercial
serotyping kit to characterize Cryptococcus isolates from
AIDS patients in southern California.
Materials and Methods
Cryptococcus Isolates
Two hundred seventy-six Cryptococcus isolates origi-
nating from patients with HIV/AIDS were obtained from
the Infectious Diseases Laboratory, Los Angeles County
Hospital, Los Angeles, California. The isolates were sus-
pended in sterile skim milk and stored at –20°C. The iso-
lates were transferred frozen to the Mycology Laboratory
of the Wadsworth Center in Albany, New York, USA,
where they were streaked on Niger seed agar plates (3) to
check for purity and reconfirmation of their identity; a typ-
ical colony was picked for further analysis. The subcul-
tures were placed in long-term storage in sterile 15%
glycerol at –70°C. These isolates were further character-
ized in our laboratory by testing their growth on canava-
nine-glycine-bromothymol blue (CGB) agar for
differentiation of Cryptococcus species (22) and serotyp-
ing with Crypto Check Kit (Iatron Laboratories Inc.,
Tokyo, Japan). Several investigators gave strains to put
together a panel of reference isolates that were either cur-
rently being used in molecular pathogenesis studies, repre-
sented type strains, or were otherwise unique. The details
of these 16 reference isolates are listed in Table 1. Six
additional A/D hybrid strains, characterized in our earlier
study, were also used (18).
Multiplex PCR for Pheromone Genes
Aprevious report from this laboratory described the use
of specific primers for amplification of MFα1 and MFa1
gene fragments, which could be separated as 100-bp and
117-bp fragments on a specialized agarose gel (21). The
primer sets V290/V291, which was earlier designed to
amplify MFa1 gene from CnVN, did not amplify similar
genes from MATa strains of either CnVG or Cg. Multiple
alignment of MFa1 indicated that this gene is highly poly-
morphic among CnVG,  CnVN, and Cg (Figure 1).
Therefore, 2 new sets of primers were designed to obtain
MFa1 amplicons from CnVG and Cg. These primers are
listed in Table 2. Amultiplex PCR for simultaneous ampli-
fication of MFα1 and MFa1 in a 50-µL reaction volume
was performed with 5 µL of 10× PCR buffer with 15
mmol/L MgCl2, 2.5 µL of each of 8 primers (10 µmol/L
stock), 3.0 µL dNTP mix (10 µmol/L each), and 2.0 U Taq
DNA polymerase (Perkin Elmer, Foster City, CA, USA).
The template DNA was 5.0 µL of either a boiled cell sus-
pension or 50 ng genomic DNA. Initial denaturation was
conducted at 95°C for 3 min, followed by 30 cycles of
denaturation at 94°C for 1 min, annealing at 57.5°C for 1
min, amplification at 72°C for 1 min, and final extension
at 72°C for 7 min, in a GeneAmp PCR System 9600
(Perkin Elmer). In preliminary experiments, PCR products
(10-µLaliquots) were resolved by electrophoresis on 3.5%
MetaPhor agarose (FMC Bio-Products, Rockland, ME,
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detected by ethidium bromide staining. The PCR experi-
ments were repeated twice, and identical results were
obtained.
Gene Scan Analysis
The MFα1 sense primer (V190) was labeled with FAM
(6-carboxyfluorescein) at the 5′ end, the antisense primer
(V191) was labeled with tetrachloro-fluorescein (TET) at
the 3′ end, and MFa1 sense primers (V290, V1311,
V1313) were labeled with 6-carboxy-2′, 4′, 4′, 5′, 7′, 7′-
hexachlorofluorescein (HEX) at the 5′ end. The fluores-
cent dye–labeled primers were custom ordered (Operon
Technologies, Inc., Alameda, CA, USA). FLA and SSCP
of the MFα1 and MFa1 PCR amplicons were determined
by CE with an ABI PRISM 310 Genetic Analyzer, and the
electronic images were analyzed by using GeneScan
analysis software (Applied Biosystems Inc., Foster City,
CA, USA). The sample preparation for CE consisted of
1  µL MFα1 and  MFa1 PCR amplicons, 12 µL highly
deionized formamide, and 0.5 µL GeneScan-500
(TAMRA) size standard (Applied Biosystems). The sam-
ple mixture was denatured for 5 min at 95°C and was then
rapidly cooled on ice before loading on the instrument. For
CE-FLA, the samples were analyzed under denaturing
conditions (POP-4 polymer [Applied Biosystems] in
buffer supplied by manufacturer) at 60°C, and for CE-
SSCP, the samples were analyzed under nondenaturing
conditions (3% GeneScan polymer in 1× TBE buffer with
10% glycerol) at 30°C. A capillary (47 cm × 50 µm inside
diameter) was installed, and POP-4 or 3% polymer was
filled according to manufacturer’s instructions. The elec-
trophoresis conditions for CE-FLAwere 5-s injection time,
15-kV injection voltage, 15-kV electrophoresis voltage,
150-s syringe pump time, 120-s preinjection electrophore-
sis, and 20-min collection time for each sample, and the
run was performed at 60°C. The electrophoresis conditions
for CE-SSCPwere 5-s injection time, 15-kVinjection volt-
age, 13-kV electrophoresis voltage, 30-s syringe pump
time with no preinjection time, and 20-min collection time
for each sample, and the run was performed at 30°C.
CE-FLA and CE-SSCP standardization experiments were
carried out on >4 independent occasions, and unknown
sample analyses were repeated at least once.
Results
Multiplex PCR
The 4 sets of primers (MFα1/MFa1) produced repro-
ducible results for control CnVG,  CnVN,  Cg haploids
(Figure 2A), and A/D hybrid strains (Figure 2B). These
results validated the robustness of the primers, which had
been designed from well within the open reading frames of
2 pheromone genes, to prevent amplification of any non-
target DNA. The latter objective also informed the deci-
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Figure 1. Primers for pheromone polymerase chain reaction
(PCR). Nucleotide sequence alignment for MFα1 and MFa1 genes
is shown with characteristic Cys-Val-Ile-Ala (CVIA) motifs. Both
sense and antisense primers were designed from within the open
reading frames of pheromone genes, to ensure high specificity of
the multiplex PCR. The MFα1 sequence from Cryptococcus neo-
formans var. grubii (CnVG) (AF542529) and the MFa1 sequences
from CnVG (AY129299), Cryptococcus neoformans var. neofor-
mans  (CnVN) (AF542530), and Cryptococcus gattii (Cg)
(AY710429) were used for multiple alignments with GCG
(Wisconsin package version 10.0). A common primer pair,
V190/V191, was designed to get MFα1 PCR amplicons from
CnVG, CnVN, and Cg (MFα1 sequence from CnVG was used as
a reference), while unique primer pairs V290/V291, V1311/V1312,
and V1313/V1314 were designed to get MFa1 PCR amplicons
from CnVN, CnVG, and Cg, respectively. All the 3′-PCR primers
contained a sequence from CVIA motif, which provided specificity
to PCRs for pheromone genes. sion to anchor the 3′ ends of all PCR primers within the
characteristic Cys-Val-Ile-Ala (CVIA) motifs; this elimi-
nated any possible amplification of other pheromone genes
since this is the only sequence shared among fungal
pheromones (18). Even though multiple copies of MFα
and MFa genes have been reported in C. gattii and C. neo-
formans by Southern hybridization and whole genome-
sequencing, PCR primers only amplify single amplicons
because these genes have identical nucleotide sequences
(18,23,24). Although this multiplex method was well suit-
ed for identifying mating types and hybrids, further delin-
eation of species and varieties would require restriction
digestion with several unique enzymes as we stated previ-
ously (21). Therefore, we decided to use CE-FLAand CE-
SSCP to further characterize pheromone gene amplicons.
These techniques have been successfully used to delineate
fragment length as well gene mutations for characterizing
various fungal and bacterial isolates (25–27). The SSCP
analysis displays migration of the amplified DNA frag-
ment as a function of that fragment’s structural conforma-
tion. Given that the tertiary structure of a fragment is
sensitive to single nucleotide substitutions, this method
was shown to be suitable for detecting single nucleotide
changes when 100-bp to 300-bp DNAfragments were ana-
lyzed (28). Since amplified pheromone fragments yield
≈100- to 120-bp products, they were an ideal substrate for
this method of mutant detection.
CE-FLA
The 16 reference strains of known Cryptococcus
species, varieties, mating types, and hybrids were used to
establish a robust CE-FLA protocol with denaturing POP-
4 polymer at 60°C. The electrophoretic runs with POP-4
polymer produced a 112-bp DNA fragment for MFa1 and
97-bp fragment for MFα1, which were easily distin-
guished with the GeneScan software by the characteristic
peak sizes (Figure 3). CE-FLAallowed Cryptococcus mat-
ing types and hybrids to be identified, but not CnVG,
CnVN, and Cg.
CE-SSCP
CE-SSCP test under nondenaturing conditions with 3%
GeneScan polymer at 30°C allowed characteristic peak
patterns to be detected in MFα1 and MFa1 genes because
of the individual differences within the nucleotide
sequences. Distinct patterns obtained for CnVG,  CnVN,
and Cg by using MFα1 gene are shown in Figure 4. The
sense strand (labeled blue) yielded 1 characteristic peak
pattern, while the antisense strand (labeled green) yielded
2–3 characteristic peak patterns. We subsequently decided
to label only the sense strand to reduce the cost of the PCR
primers as well the complexity of the peak patterns
observed with antisense strand. For determining an
unknown sample, the instrument analyses needed to yield
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Figure 2. Multiplex polymerase chain reaction (PCR) for
pheromone fragment analysis. A) Multiplex PCR with 4 sets of
primers comprising MFα1 (V190/V101) and MFa1 (V290/V291,
V1311/V1312, V1313/V1314) genes were carried out as described
in Materials and Methods. Approximately 100-bp MFα1 and 117-bp
MFa1 PCR amlicons were detected on 3.5% MetaPhor agarose in
Tris-borate-EDTA buffer for MATα and MATa strains comprising
Cryptococcus neoformans var. grubii (CnVG), Cryptococcus neo-
formans  var. neoformans (CnVN), and Cryptococcus gattii (Cg)
Lanes 1 and 7, molecular mass marker. B) Multiplex PCR depict-
ing MFα1 and MFa1 PCR amplicons from the 8 known hybrid
(A/D) isolates. Lane 1, molecular mass marker.
Figure 3. Capillary electrophoresis fragment-length analyses (CE-
FLA) for the identification of mating types and hybrids. The ABI
PRISM 310 Genetic Analyzer and GeneScan analysis software
were used for the fragment length analysis of the pheromone
genes. Sense strands of MFα1 and MFa1 were labeled with fluo-
rescent probes TET (green) and HEX (black), respectively, and
polymerase chain reaction amplicons were analyzed with POP-4
polymer under denaturing conditions at 60°C. Green peak, MFα1;
black peak, MFa1. These peaks were aligned by using an internal
size standard, GeneScan-500 TAMRA (red peaks).highly reproducible results. Therefore, a sample of each of
the Cryptococcus strains was injected on 4 separate occa-
sions into the same capillary, and the precision of the
sizing was calculated. The low standard deviations associ-
ated with each mean peak value indicated that the assign-
ment of variety or species for an unknown sample, based
on pattern sizing information alone, would be highly reli-
able (Table 3).
Based on our success with MFα1 sense primer in the
detection of characteristic peaks for CnVG, CnVN, and Cg,
we labeled MFa1 sense strands and analyzed MATa
strains. In this case, we had to use individual sets of MFa1
primers because of the substantial polymorphism observed
at the 5′ and 3′ end of this gene between Cg and Cn, and
within Cn vatieties (Figure 1). Again, the MFa1 peak pat-
tern was unique to each Cn variety and Cg (Table 3).
Overall, our results indicated that either MFα1 or MFa1
gene products yielded unique SSCP patterns and could be
used for identifying Cn varieties and Cg strains.
California Isolates
We used standardized CE-FLA and CE-SSCP tech-
niques to analyze 276 isolates of Cryptococcus that were
obtained from AIDS patients and that were stored at the
Infectious Diseases Laboratory, Los Angeles County
Hospital, Los Angeles, California. The investigations were
fully compliant with Los Angeles County Hospital–
University of Southern California (USC) Institutional
Review Board guidelines (proposal #924008). CE-FLA
showed that all 276 isolates were MATα strains, and no
MATa or hybrid strains were found in our samples. CE-
SSCP found that among the total 276 clinical isolates, 219
(79.3%) were CnVG, 23 (8.3%) were CnVN, and 34
(12.3%) were Cg. For corroborations, all of these isolates
were also tested by growth on CGB agar, and by serotyping
with the Crypto Check Kit, both of which yielded results in
agreement with those obtained with pheromone typing.
Discussion
The relatively high prevalence of Cg in this survey is
noteworthy for several reasons (Table 4). First, we believe
it is the first instance in which a large number of Cg clini-
cal isolates from AIDS patients have been identified in the
United States. Second, Cg has never been considered a
substantial cause of cryptococcosis among US AIDS
patients, including those in the southern California. Third,
the presence of Cg in HIV-AIDS patient samples in the
USC collection is similar to the prevalence recently report-
ed from some countries in Central and South America (29),
and it contrasts with the rare occurrence of Cg in immuno-
compromised patient populations in Australia, Southeast
Asia, and Africa (30–32). The prevalence of CnVN (8%) in
our samples closely matches its recently reported preva-
lence in New York City (33). Thus, cryptococcosis due to
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Figure 4. Capillary electrophoresis–single strand conformation
polymorphisms (CE-SSCP) for the identification of varieties and
species. The ABI PRISM 310 Genetic Analyzer and GeneScan
analysis software were used for variety and species determination
with the MFα1 pheromone gene. The MFα1 sense and antisense
primers were labeled with fluorescent probes FAM (blue) and TET
(green), and and polymerase chain reaction amplicons were ana-
lyzed with 3% polymer at 30°C under nondenaturing conditions.
The blue and green peaks depict characteristic peak pattern for
Cryptococcus neoformans var. grubii (CnVG), Cryptococcus neo-
formans var. neoformans (CnVN), and Cryptococcus gattii (Cg).
These peaks were aligned by using an internal size standard.CnVN in AIDS patients is not a rare clinical entity in the
United States, and its pattern of distribution on the East
and West Coasts does not differ. The absence of MATa
strains in our samples is not surprising, in view of the rare
occurrence of this mating type among clinical and environ-
mental specimens (34). This finding is consistent with the
results of other recent clinical and environmental surveys
in the United States, Europe, and Australia. The Cg out-
break on Vancouver Island also yielded only MATα iso-
lates (8,35). Overall, our inferences are based on limited
data, since most published studies on cryptococcosis do
not include detailed characterization of Cryptococcus
strains. Future epidemiologic studies will likely yield a
more complete picture of the causative varieties or species
of Cryptococcus across the United States.
As previously noted, CnVG infections are predominant
in AIDS patients around the world, except in Europe,
where CnVN is seen in sizable numbers. One explanation
for this phenomenon is that CnVG is best adapted for the
colonization of soil and pigeon droppings. However,
CnVN may dominate the same ecologic niche in parts of
Europe for undetermined causes (10). The lower incidence
of Cg infection in AIDS patients could be due to the pauci-
ty of regions around the world in which Cg is endemic and
the reported association of Cg disease with the flowering
of Eucalyptus camaldulensis trees in certain areas (6). The
unprecedented outbreak of Cg infection in Vancouver
Island already comprises 66 human and 50 animal cases of
cryptococcosis. Ongoing investigation in Vancouver Island
indicate that the numbers of human and animal cases are
increasing (130 human cases and >200 animal cases),
which led to the recent change in the definition of Cg out-
break to Cg endemicity in this region (7). Additionally, Cg
was isolated from swab samples from the bark of trees of
many species (alder, arbutus, bitter cherry, cedar, fir, garry
oak, maple, spruce), as well as from soil and air samples
near these trees (7). These investigations have added a new
dimension to our understanding of Cg ecology and suggest
that this pathogen is neither restricted in its geographic dis-
tribution nor to its presumed natural host, Eucalyptus trees.
Our results indicated that both CE-FLA and CE-SSCP
of pheromone genes are amenable to semi-automation and
large-scale analyses of pathogenic Cryptococcus species,
varieties, mating types, and hybrids. Each step of this
analysis, namely, PCR, heat denaturation with formamide,
and subsequent loading of samples, can be carried out in
48- or 96-well trays, which allow the use of multichannel
or automated pipettors. Both CE-FLA and CE-SSCP indi-
vidual runs are completed in <20 min, and the instrument
can be programmed for multiple runs, thereby giving a
high throughput. Thus, analyzing hundreds to thousands of
strains is a good possibility, especially in reference labora-
tories. Moreover, the electrophoretic runs are saved as
electronic files for easy portability over the Internet and to
facilitate interlaboratory comparisons. This study reports a
logical improvement over our earlier published method on
pheromone PCR-RFLP for characterizing Cryptococcus
isolates. The use of CE-FLA and CE-SSCP allowed us to
dispense with running specialized gels as well as the use of
unique restriction digestion schemes (21). Thus, CE-FLA
alone leads to visualization of size differences in MFα1
versus MFa1 pheromones, which would distinguish mat-
ing types and hybrids. The species and varieties could be
distinguished by CE-SSCP on the basis of polymorphisms
in nucleotide sequences of MFα1 and MFa1 in Cg, CnVG,
and  CnVN. Thus, 1 typing method had the potential to
replace multiple tests, such as specialized media and
serotyping kits for species/variety determination, crossing
with tester strains on mating agar, and flow cytometry for
hybrid determination. The current limitations of this
approach include the use of 2 polymers and run tempera-
tures, which makes it necessary to run CE-FLA and CE-
SSCP as batch applications on ABI 310 Genetic Analyzer.
Since individual electrophoretic runs are completed in ≈20
min, ≈16 hours will be necessary to analyze ≈45 samples
(one 48-sample tray) by CE-FLA, followed by change of
polymer and run conditions, and another 16 hours to com-
plete CE-SSCP analyses. However, these limitations could
be easily overcome in the upgraded model of this instru-
ment (ABI 3130), which has 4–16 capillaries and hands-
free, 24-hour operation capabilities for simultaneous
analyses of multiple samples, thereby considerably
decreasing turnaround time.
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